References
- Shaffer BL, Caughey AB, Norton ME. Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenat Diagn. 2006;26(8):667–671.
- American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 135: second-trimester abortion. Obstet Gynecol. 2013;121:1394–1406.
- Henshaw SK, Finer LB. The accessibility of abortion services in the United States, 2001. Perspect Sex Reprod Health. 2003;35(1):16–24.
- Autry AM, Hayes EC, Jacobson GF, et al. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol. 2002;187(2):393–397.
- Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99(suppl 2):S160–S7.
- Feldman DM, Borgida AF, Rodis JF, et al. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. Am J Obstet Gynecol. 2003;189(3):710–713.
- Ho PC. Women’s perceptions on medical abortion. Contraception. 2006;74(1):11–15.
- Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17(2):332–336.
- Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstet Gynecol. 2003;101(6):1294–1299.
- Cabrera Y, Fernandez-Guisasola J, Lobo P, et al. Comparison of sublingual versus vaginal misoprostol for second-trimester pregnancy termination: a meta-analysis. Aust N Z J Obstet Gynaecol. 2011;51(2):158–165.
- von Hertzen H, Piaggio G, Huong NT, et al. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet. 2007;369(9577):1938–1946.
- Guix C, Palacio M, Figueras F, et al. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination. Fetal Diagn Ther. 2005;20(6):544–548.
- Bebbington MW, Kent N, Lim K, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol. 2002;187(4):853–857.
- Arvidsson C, Hellborg M, Gemzell-Danielsson K. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone. Eur J Obstet Gynecol Reprod Biol. 2005;123(1):87–91.
- Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet. 1991;338(8777):1233–1236.
- Nautiyal D, Mukherjee K, Perhar I, et al. Comparative study of misoprostol in first and second trimester abortions by oral, sublingual, and vaginal routes. J Obstet Gynaecol India. 2015;65(4):246–250.
- Wildschut H, Both MI, Medema S, et al. Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev. 2011;1:CD005216.
- Green J, Borgatta L, Sia M, et al. Intervention rates for placental removal following induction abortion with misoprostol. Contraception. 2007;76(4):310–313.
- Tang J, Kapp N, Dragoman M, et al. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet. 2013;121(2):186–189.
- Perritt JB, Burke A, Edelman AB. Interruption of nonviable pregnancies of 24–28 weeks’ gestation using medical methods: release date June 2013 SFP guideline #20133. Contraception. 2013;88(3):341–349.
- Ngoc NT, Shochet T, Raghavan S, et al. Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol. 2011;118(3):601–608.
- Langer BR, Peter C, Firtion C, et al. Second and third medical termination of pregnancy with misoprostol without mifepristone. Fetal Diagn Ther. 2004;19(3):266–270.
- Choudhary N, Bagga R, Raveendran A, et al. Second trimester abortion in women with and without previous uterine scar: eleven years experience from a developing country. Eur J Contracept Reprod Health Care. 2011;16(5):378–386.